Assessing Clinical Response in Multiple Myeloma (MM) Patients Treated With Monoclonal Antibodies (Mabs): Validation of a Daratumumab IFE Reflect Assay (DIRA) to Distinguish Malignant M-Protein From Therapeutic Antibody

Poster – Assessing Clinical Response in Multiple Myeloma (MM) Patients Treated With Monoclonal Antibodies (Mabs)

Reach out to our experts and discover how we can help advance your clinical trial